Patient-Reported Financial Distress in Cancer: A Systematic Review of Risk Factors in Universal Healthcare Systems.

cancer financial distress financial toxicity risk factors universal healthcare coverage

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
07 Oct 2021
Historique:
received: 15 06 2021
revised: 23 09 2021
accepted: 04 10 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 14 10 2021
Statut: epublish

Résumé

Financial toxicity is a side effect of cancer that results from the perceived financial distress an individual may experience in the course of the disease. The purpose of this paper is to analyse underlying factors related to subjective financial distress in high-income countries with universal healthcare coverage. A systematic literature review was conducted to identify qualitative and quantitative studies of cancer patient-reported subjective financial distress by performing a search in the databases of PubMed, PsycINFO and CINAHL up to December 2020. A qualitative synthesis was performed linking the time-dependent occurrence of risk factors to derived categories of risk factors. Out of 4321 identified records, 30 quantitative and 16 qualitative studies were eligible. Classification of risk factors resulted in eight categories with a total of 34 subcategories. Subjective financial distress is primarily determined by pre-diagnosis sociodemographic- factors as well as financial and work factors that might change during the course of the disease. The design of healthcare and social security systems shapes the country-specific degree of subjective financial distress. Further research should focus on evolving multidisciplinary intervention schemes and multidimensional instruments for subjective financial distress to account for identified risk factors in universal healthcare systems more precisely.

Identifiants

pubmed: 34638499
pii: cancers13195015
doi: 10.3390/cancers13195015
pmc: PMC8508394
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Deutsche Krebshilfe
ID : 701134038

Références

PLoS One. 2017 May 18;12(5):e0176470
pubmed: 28545063
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 28771857
BMC Health Serv Res. 2010 Sep 03;10:259
pubmed: 20815908
J Clin Oncol. 2016 May 20;34(15):1732-40
pubmed: 26926678
BMC Cancer. 2020 Jun 5;20(1):529
pubmed: 32503459
PLoS One. 2012;7(8):e42979
pubmed: 22900073
Support Care Cancer. 2020 Mar;28(3):1131-1139
pubmed: 31201545
Asia Pac J Clin Oncol. 2021 Jun;17(3):245-252
pubmed: 32894819
J Glob Oncol. 2019 May;5:1-8
pubmed: 31070981
J Cancer Surviv. 2019 Feb;13(1):10-20
pubmed: 30357537
J Cancer Surviv. 2021 Mar 15;:
pubmed: 33723742
Health Expect. 2004 Mar;7(1):40-50
pubmed: 14982498
J Clin Oncol. 2016 Mar 20;34(9):980-6
pubmed: 26811521
Aust J Rural Health. 2020 Dec;28(6):588-602
pubmed: 33382474
Aust J Rural Health. 2011 Dec;19(6):298-305
pubmed: 22098213
Psychooncology. 2012 Nov;21(11):1167-74
pubmed: 21769990
Support Care Cancer. 2015 Mar;23(3):889-98
pubmed: 25337681
Ann Oncol. 2019 Jul 1;30(7):1061-1070
pubmed: 31046080
Clin Lung Cancer. 2019 Jul;20(4):231-236
pubmed: 30797721
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Acta Oncol. 2019 Jul;58(7):1062-1068
pubmed: 30943813
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1184-1192
pubmed: 31590147
Eur J Cancer Care (Engl). 2017 Jan;26(1):
pubmed: 26423576
Can Oncol Nurs J. 2020 Apr 1;30(2):113-118
pubmed: 33118999
Psychooncology. 2019 Apr;28(4):863-871
pubmed: 30779397
Breast Cancer Res Treat. 2019 Jun;175(2):499-510
pubmed: 30826935
Chronic Illn. 2007 Dec;3(4):265-77
pubmed: 18083681
Acta Oncol. 2017 Feb;56(2):190-197
pubmed: 28055266
J Psychosoc Oncol. 2013;31(1):83-102
pubmed: 23311973
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13051
pubmed: 31033073
Oncologist. 2019 Aug;24(8):1121-1127
pubmed: 30877191
Aust J Rural Health. 1999 Feb;7(1):43-52
pubmed: 10373815
Support Care Cancer. 2009 Aug;17(8):1057-64
pubmed: 19037665
Oncology (Williston Park). 2013 Feb;27(2):80-1, 149
pubmed: 23530397
Support Care Cancer. 2021 Jan;29(1):485-490
pubmed: 32405963
PLoS One. 2013 Nov 11;8(11):e77549
pubmed: 24244279
Sociol Health Illn. 2015 Nov;37(8):1191-205
pubmed: 26139163
BMJ Open. 2019 Sep 9;9(9):e031485
pubmed: 31501130
Cancer. 2017 Feb 1;123(3):476-484
pubmed: 27716900
J Natl Cancer Inst. 2015 Dec 11;108(5):
pubmed: 26657334
Patient Educ Couns. 2021 Apr;104(4):903-910
pubmed: 32843264
Support Care Cancer. 2020 Dec;28(12):5693-5708
pubmed: 32865673
Cancer. 2020 Sep 1;126(17):4042-4050
pubmed: 32603521
Ann Epidemiol. 2009 Dec;19(12):850-7
pubmed: 19944348
J Psychosoc Oncol. 2018 Sep-Oct;36(5):582-596
pubmed: 30235067
Support Care Cancer. 2014 Feb;22(2):519-26
pubmed: 24136158
Support Care Cancer. 2016 Feb;24(2):699-709
pubmed: 26143038
Int J Circumpolar Health. 2015 Jan 22;74:26686
pubmed: 25623815
Curr Oncol. 2021 Mar 15;28(2):1216-1248
pubmed: 33804288
Jpn J Clin Oncol. 2012 Aug;42(8):704-10
pubmed: 22581912
Asian Pac J Cancer Prev. 2016;17(5):2459-64
pubmed: 27268614
Support Care Cancer. 2019 Jun;27(6):2221-2228
pubmed: 30315427
Patient. 2017 Jun;10(3):295-309
pubmed: 27798816
Patient. 2020 Jun;13(3):363-373
pubmed: 32072460
CA Cancer J Clin. 2018 Mar;68(2):153-165
pubmed: 29338071
Acta Oncol. 2019 May;58(5):811-818
pubmed: 30777496
Aust Health Rev. 2000;23(3):94-103
pubmed: 11186065
Support Care Cancer. 2020 Oct;28(10):4645-4665
pubmed: 32653957
Psychooncology. 2018 Sep;27(9):2165-2171
pubmed: 29852528
Support Care Cancer. 2013 Jan;21(1):107-17
pubmed: 22987093
Support Care Cancer. 2016 May;24(5):2225-2233
pubmed: 26573280
J Rural Health. 2013 Aug;29 Suppl 1:s43-50
pubmed: 23944279
J Clin Oncol. 2004 Dec 1;22(23):4829-36
pubmed: 15570086
Acta Oncol. 2013 Aug;52(6):1119-28
pubmed: 23514583
Onkologe (Berl). 2021 Jun 18;:1-6
pubmed: 34177129

Auteurs

Sophie Pauge (S)

Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, 33615 Bielefeld, Germany.

Bastian Surmann (B)

Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, 33615 Bielefeld, Germany.

Katja Mehlis (K)

Section of Translational Medical Ethics, Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Andrea Zueger (A)

Section of Translational Medical Ethics, Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Luise Richter (L)

Methods in Empirical Social Research, Institute of Sociology, Faculty of Arts, Humanities and Social Science, Dresden University, 01062 Dresden, Germany.

Natalja Menold (N)

Methods in Empirical Social Research, Institute of Sociology, Faculty of Arts, Humanities and Social Science, Dresden University, 01062 Dresden, Germany.

Wolfgang Greiner (W)

Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, 33615 Bielefeld, Germany.

Eva C Winkler (EC)

Section of Translational Medical Ethics, Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, 69120 Heidelberg, Germany.

Classifications MeSH